AI-generated analysis. Always verify with the original filing.
Cardlytics, Inc. announced Q4 and full year 2025 financial results, reporting total revenue of $56.1 million for Q4 (down 24.2% YoY) and $233.3 million for the year (down 16.2% YoY), with improved Adjusted EBITDA and reduced net losses. The company provided Q1 2026 guidance anticipating Billings of $57.5-$63.5 million and Revenue of $35.0-$40.0 million.
Event Type
Disclosure
Mandatory
Variant
8-K
and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits Exhibit Exhibit Description 99.1 Press release dated March 4, 2026 SIGNATURES Pursuant to the requirements of the
| Metric | Value | Basis |
|---|---|---|
| Revenue | $233.27 | GAAP |
| Net Loss | $-103.49 | GAAP |
| Diluted EPS | $-1.95 | GAAP |
| Adjusted EBITDA | $10.06 | Non-GAAP |
Billings
57.5 - 63.5
Non-GAAP
Revenue
35.0 - 40.0
GAAP
Adjusted Contribution
20.0 - 23.0
Non-GAAP
Adjusted EBITDA
-7.5 - -3.5
Non-GAAP